The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease | Nature Reviews Neuroscience
Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2 | PNAS
Leucine-rich repeat kinase 2 (LRRK2) and Parkinson's disease: from genetics to pathobiology - ScienceDirect
Glucocerebrosidase 1 and leucine‐rich repeat kinase 2 in Parkinson disease and interplay between the two genes - Lee - 2021 - Journal of Neurochemistry - Wiley Online Library
Leucine-rich repeat kinase 2 (LRRK2) is expressed in dendritic cells... | Download Scientific Diagram
Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors | Journal of Medicinal Chemistry
The Kinase domain of Leucine-Rich Repeat Kinase 2 (LRRK2). (A)... | Download Scientific Diagram
IJMS | Free Full-Text | Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells
PDF] Identification & characterization of leucine-rich repeat kinase 2 & parkin RBR E3 ubiquitin protein ligase variants in patients with Parkinson's disease by Tamali Halder, Shiv Prakash Verma, Janak Raj, Sharad Pandey,
Leucine-rich repeat kinase 2: Relevance to Parkinson's disease - ScienceDirect
Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease | Future Medicinal Chemistry
Leucine-rich repeat kinase 2 (LRRK2) is localized on lysosomes and... | Download Scientific Diagram
Leucine‐rich repeat kinase 2 and lysosomal dyshomeostasis in Parkinson disease - Cogo - 2020 - Journal of Neurochemistry - Wiley Online Library
Frontiers | Leucine Rich Repeat Kinase 2 and Innate Immunity
LRRK2 and idiopathic Parkinson's disease: Trends in Neurosciences
LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review | Journal of Biomedical Science | Full Text
Leucine-Rich Repeat Kinase 2-Linked Parkinson's Disease: Clinical and Molecular Findings
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease: Trends in Pharmacological Sciences
Frontiers | LRRK2 Phosphorylation, More Than an Epiphenomenon
PDF] Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions | Semantic Scholar